This is pointing towards HK2 as a negative regulator of RLR signaling in HCC cells and suggests that the GCK-to-HK2 isoenzyme switch during malignant transformation of hepatocytes is accompanied by a reduced sensitivity to innate immune signals. This evidence concerns the gene GCK and hepatocellular carcinoma.